Source:http://linkedlifedata.com/resource/pubmed/id/16230137
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2005-10-18
|
| pubmed:abstractText |
To expand the clinical use of botulinum toxin A (BTX-A) in treating patients with small prostates and symptomatic benign prostatic hyperplasia (BPH). BTX-A injection into the prostate in patients with voiding dysfunction and large prostates has been reported.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
1527-9995
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
66
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
775-9
|
| pubmed:dateRevised |
2010-11-18
|
| pubmed:meshHeading | |
| pubmed:year |
2005
|
| pubmed:articleTitle |
Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates.
|
| pubmed:affiliation |
Division of Urology, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
|
| pubmed:publicationType |
Journal Article
|